Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O4CV
|
||||
Former ID |
DIB009258
|
||||
Drug Name |
Dihydroergotamine nasal
|
||||
Synonyms |
Dihydroergotamine; Levadex; Tempo Migraine; Inhaled DHE, Sheffield; MAP-0004; Tempo dyhydroergotamine, Sheffield; Nasal DHE (migraine), Britannia; Dihydroergotamine (inhaled, Tempo), MAP; Dihydroergotamine (nasal, migraine), Britannia; Dihydroergotamine (inhaled/oral, Tempo), Sheffield; Dihydroergotamine (migraine,Tempo-inhaled/oral), MAP
|
||||
Indication | Migraine [ICD9: 346; ICD10:G43] | Approved | [551730] | ||
Therapeutic Class |
Neurology Agents
|
||||
Company |
Britannia Pharmaceuticals Ltd; allergan; map pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
[C@@]12(N(C(=O)[C@@](O1)(NC(=O)[C@@H]1C[C@H]3[C@H](N(C1<br />)C)Cc1c4c3cccc4[nH]c1)C)[C@H](C(=O)N1[C@H]2CCC1)Cc1cccc<br />c1)O
|
||||
CAS Number |
CAS 511-12-6
|
||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 1B receptor | Target Info | Modulator | [534635] | |
5-hydroxytryptamine 1D receptor | Target Info | Modulator | [534635] | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.